WATSON 582 (Propafenone 150 mg)
Pill with imprint WATSON 582 is White, Round and has been identified as Propafenone hydrochloride 150 mg. It is supplied by Watson Laboratories, Inc..
Propafenone is used in the treatment of atrial fibrillation; wolff-parkinson-white syndrome; atrial flutter; ventricular tachycardia and belongs to the drug class group I antiarrhythmics. Risk cannot be ruled out during pregnancy. Propafenone 150 mg is not a controlled substance under the Controlled Substance Act (CSA).
Images for WATSON 582
- WATSON 582
- 150 mg
- 9.00 mm
- Prescription only
- Drug Class:
- Group I antiarrhythmics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Watson Laboratories, Inc.
- Inactive Ingredients:
- silicon dioxide
sodium lauryl sulfate
Note: Inactive ingredients may vary.
Other Labelers / Repackagers:
|NDC Code||Labeler / Repackager|
|68084-0361||Amerisource Health Services|
|63739-0509||McKesson Packaging Services|
|54868-4770||Physicians Total Care Inc (repackager)|
More about propafenone
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 45 Reviews – Add your own review/rating
- Drug class: group I antiarrhythmics
- Propafenone Tablets
- Propafenone Sustained-Release Capsules
- Propafenone (Advanced Reading)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.